Unbiased classification of equine dendritic cells (DC) is necessary to address various research questions such as the role of DC subsets in immune-mediated diseases of horses. We applied single-cell RNA sequencing (scRNA-seq) on DC enriched from the blood of two horses. All main DC subsets were detected by key gene expression, including conventional DC type 1 (cDC1; XCR1 ) and type 2 (cDC2; FCER1A , CD1E ) as well as plasmacytoid DC (pDC; TCF4 ). In addition, we detected a small cluster of hematopoietic progenitors, as well as transitional DC (tDC; FCER1A , TCF4 ) and putative DC type 3 (DC3; FLT3 , CD163 ). Our data confirms the previously reported phenotype of equine pDC (Flt3 + MHC-II low CADM1 low CD172a int ), cDC1 (Flt3 + MHC-II high CADM1 high CD172a low-int ) and cDC2 (Flt3 + MHC-II high CADM1 int CD172a high ), while also highlighting considerable CD14 expression for cDC2. Two subclusters of equine cDC2 were found to be enriched in FCER1A or CX3CR1 transcripts (cDC2.1 and cDC2.2, respectively), with suggested enhanced extravasation and T-cell stimulatory capacities of the latter. Conservation of DC subsets across species (horse, pig, human, mouse) was illustrated by enrichment analyses with subset-specific gene signatures and by cross-species data integration with publicly available scRNA-seq datasets. Our atlas of equine blood DC is a valuable resource for comparative analyses, and it forms the foundation for understanding the involvement of distinct DC subsets in infections and immune-mediated pathologies. Abstract Figure:
Histopathology and immunohistochemistry (IHC) are central to COVID-19 tissue evaluation. However, conventional manual scoring is limited by its semiquantitative nature and potential observer variability. In this retrospective study of experimentally infected mice, we implemented a semi-automated digital pathology workflow using commercially available software to quantitatively assess SARS-CoV-2 nucleocapsid (N) immunolabeling in lung (n = 135) and brain (n = 67) tissues. The performance of digital quantification was evaluated against conventional manual scoring, and its association with virological and pathological parameters was assessed across different stages of disease progression. Digital IHC quantification demonstrated strong agreement with manual scoring in both lung [R = 0.94, p < 0.0001, concordance correlation coefficient (CCC) = 0.95] and brain [R = 0.98, p < 0.0001; CCC = 0.977], demonstrating concordance between the two approaches. In addition, digital SARS-CoV-2 N immunolabeling quantification showed significant positive correlations with viral RNA levels, infectious viral titers, and histopathological scores, supporting its association with independent measures of SARS-CoV-2 infection and lesions. Although computational image analysis requires additional infrastructure, technical expertise, and increased analysis time, it provides an objective continuous quantitative measure of SARS-CoV-2 N immunolabeling that complements conventional manual assessment and may reduce observer-dependent variability.
Histopathology and immunohistochemistry (IHC) are central to COVID-19 tissue evaluation. However, conventional manual scoring is limited by certain subjectivity and its semiquantitative nature. In this retrospective study of experimentally infected mice, we implemented a deep learning-based digital pathology workflow using com-mercially available software to quantitatively assess SARS-CoV-2 antigen burden in lung (n=135) and brain (n=67) tissues. The performance of digital quantification was evaluated against conventional manual scoring, and its biological relevance was as-sessed by correlation with established virological and pathological parameters across different stages of disease progression. Digital IHC quantification demonstrated near-perfect agreement with manual scoring in both lung [R=0.94, p< 0.0001, concord-ance correlation coefficient (CCC)=0.969] and brain (R=0.98, p< 0.0001; CCC=0.98) in-dicating high reproducibility and accuracy. In addition, digital antigen quantification showed significant positive correlations with viral RNA levels, infectious viral titers, and histopathological scores, indicating that it provides biologically meaningful readout of SARS-CoV2 infection. Although computational image analysis requires ad-ditional infrastructure, technical expertise, and increased analysis time, these invest-ments provide a more objective and reproducible alternative to the traditional manual gold standard while generating quantitative data that enable a more precise assess-ment of SARS-CoV-2–associated disease.
Dendritic cells (DC) are professional antigen presenting cells playing a major role in orchestrating adaptative immune responses. To adapt to various immune challenges, such as different classes of pathogens, specialized subsets of DC have evolved across species. To date, DC are classified as conventional DC (cDC1, cDC2) and plasmacytoid DC (pDC), with the more recent addition of DC3 and transitional DC (tDC) that were discovered in human and mouse thanks to high-dimensional phenotyping and single-cell sequencing technologies. Here, by combining flow cytometry and RNA-seq on the bulk- and single-cell level, we identified the porcine equivalent of tDC in blood as CD14 - CADM1 - CD172a + CD4-cells expressing both Flt3 and CD123 (IL-3RA). This new subset forms a well-defined cluster when mapped onto scRNA-seq data of enriched DC and shares transcriptomic features and abundance with porcine blood cDC2 and pDC. Moreover, we describe putative porcine DC3 as transcriptionally overlapping cells in-between cDC2 and monocytes. With the core functions of tDC and DC3 remaining to be elucidated, our datasets provide a valuable resource for cross-species research on DC heterogeneity in various lymphoid and non-lymphoid tissues.